Zacks Small Cap Research on MSN
MDAI: In the blocks, ready to go upon mid-year authorization
MDAI READ THE FULL MDAI RESEARCH REPORT It has now been approximately seven months since Spectral AI, Inc. (NASDAQ:MDAI) announced its De Novo marketing application to the FDA for the DeepView device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback